SCHEMBL7582928

SCHEMBL7582928

O=C1c2ccccc2C(=O)N1C[C@H]1CC[C@H](C(=O)O)CC1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 1/20 0.50
KAT2A Q92830 1/20 0.50
KAT2B Q92831 1/20 0.50
CYP1B1 Q16678 3/20 0.49
CA12 O43570 1/20 0.49
CA9 Q16790 1/20 0.49
BACE1 P56817 1/20 0.48
BACE2 Q9Y5Z0 1/20 0.48
TRPA1 O75762 2/20 0.48
MMP2 P08253 3/20 0.47
MMP3 P08254 3/20 0.47
MMP9 P14780 3/20 0.47
MMP13 P45452 3/20 0.47
MMP1 P03956 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
KEAP1 Q14145 1/20 0.44
ACHE P22303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30657546 1.00 CREBBP (0.50) CREBBPKAT2AKAT2BCYP1B1CA12
SCHEMBL7582920 1.00 CREBBP (0.50) CREBBPKAT2AKAT2BCYP1B1CA12
SCHEMBL30657547 1.00 CREBBP (0.50) CREBBPKAT2AKAT2BCYP1B1CA12
SCHEMBL1581709 0.87 CYP1B1 (0.59) CYP1B1CA12CA9TRPA1CYP1A2
SCHEMBL11893773 0.85 KMT2A (0.53) CREBBPKAT2AKAT2BCYP1B1BACE1
SCHEMBL11949739 0.85 KMT2A (0.53) CREBBPKAT2AKAT2BCYP1B1BACE1
SCHEMBL12798790 0.85 KMT2A (0.53) CREBBPKAT2AKAT2BCYP1B1BACE1
SCHEMBL28872170 0.82 CYP1B1 (0.52) CYP1B1CA12CA9TRPA1CYP1A2
SCHEMBL21598051 0.82 CYP1A2 (0.54) CYP1B1CA12CA9TRPA1CYP1A2
Cyanide SCHEMBL27937317 0.82 CYP1B1 (0.55) CYP1B1CA12CA9TRPA1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772590-B1 THROMBIN INHIBITORS MERCK & CO INC (US) 2002-10-09 EP disclosed
EP-1129076-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 2001-09-05 EP disclosed
US-6117880-A TREATMENT OF DIABETES, RETINOPATHY, RESTINOSIS, ACROMEGALY, AND DEPRESSION MERCK & CO., INC. (US) 2000-09-12 US disclosed
WO-2000029380-A1 TETRAHYDROISOQUINOLINE DERIVATIVES AS LHRH ANTAGONISTS ABBOTT LABORATORIES (US) 2000-05-25 WO disclosed
US-6057338-A USEFUL IN THE TREATMENT OF DIABETES, CANCER, ACROMEGALY, RESTENOSIS, DEPRESSION, IRRITABLE BOWEL SYNDROME, PAIN AND DIABETIC RETINOPATHY MERCK & CO., INC. (US) 2000-05-02 US disclosed
US-5981521-A USEFUL FOR TREATING VARIOUS HORMONE DEPENDENT DISEASES, INCLUDING PROSTATE CANCER, ENDOMETRIOSIS, UTERINE FIBROIDS, PRECOCIOUS PUBERTY, BENIGN PROSTATE HYPERTROPY AND IN VITRO FERTILIZATION ABBOTT LABORATORIES (US) 1999-11-09 US disclosed
US-5714485-A Piperidine and hexahydropyridazine thrombin inhibitors MERCK & CO., INC. (US) 1998-02-03 US disclosed
US-5510369-A ANTICOAGULANTS MERCK & CO., INC. (US) 1996-04-23 US disclosed